搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Arabidopsis lyrata Defensin-like SRCA-homolog protein (SCR37) CSB-YP498289DNY
CSB-EP498289DNY
CSB-BP498289DNY
CSB-MP498289DNY
CSB-EP498289DNY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi Citrate lyase acyl carrier protein (citD) CSB-YP498290FMI
CSB-EP498290FMI
CSB-BP498290FMI
CSB-MP498290FMI
CSB-EP498290FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi Glycerol-3-phosphate dehydrogenase [NAD (P)+] CSB-YP498291FMI
CSB-EP498291FMI
CSB-BP498291FMI
CSB-MP498291FMI
CSB-EP498291FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi 50S ribosomal protein L23 (rplW) CSB-YP498292FMI
CSB-EP498292FMI
CSB-BP498292FMI
CSB-MP498292FMI
CSB-EP498292FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi Bifunctional protein pyrR (pyrR) CSB-YP498293FMI
CSB-EP498293FMI
CSB-BP498293FMI
CSB-MP498293FMI
CSB-EP498293FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi Holliday junction resolvase recU (recU) CSB-YP498294FMI
CSB-EP498294FMI
CSB-BP498294FMI
CSB-MP498294FMI
CSB-EP498294FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi 30S ribosomal protein S13 (rpsM) CSB-YP498295FMI
CSB-EP498295FMI
CSB-BP498295FMI
CSB-MP498295FMI
CSB-EP498295FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B CSB-YP498296FMI
CSB-EP498296FMI
CSB-BP498296FMI
CSB-MP498296FMI
CSB-EP498296FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi Uracil phosphoribosyltransferase (upp) CSB-YP498297FMI
CSB-EP498297FMI
CSB-BP498297FMI
CSB-MP498297FMI
CSB-EP498297FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP498298FMI
CSB-EP498298FMI
CSB-BP498298FMI
CSB-MP498298FMI
CSB-EP498298FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi 3-oxoacyl-[acyl-carrier-protein] synthase 3 (fabH) CSB-YP498299FMI
CSB-EP498299FMI
CSB-BP498299FMI
CSB-MP498299FMI
CSB-EP498299FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi HPr kinase/phosphorylase (hprK) CSB-YP498300FMI
CSB-EP498300FMI
CSB-BP498300FMI
CSB-MP498300FMI
CSB-EP498300FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase CSB-YP498301FMI
CSB-EP498301FMI
CSB-BP498301FMI
CSB-MP498301FMI
CSB-EP498301FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi Protein sprT-like (SEQ_1541) CSB-YP498302FMI
CSB-EP498302FMI
CSB-BP498302FMI
CSB-MP498302FMI
CSB-EP498302FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi 50S ribosomal protein L28 (rpmB) CSB-YP498303FMI
CSB-EP498303FMI
CSB-BP498303FMI
CSB-MP498303FMI
CSB-EP498303FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi 50S ribosomal protein L16 (rplP) CSB-YP498304FMI
CSB-EP498304FMI
CSB-BP498304FMI
CSB-MP498304FMI
CSB-EP498304FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi Ribosome-binding factor A (rbfA) CSB-YP498305FMI
CSB-EP498305FMI
CSB-BP498305FMI
CSB-MP498305FMI
CSB-EP498305FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi D-alanine--D-alanine ligase (ddl) CSB-YP498306FMI
CSB-EP498306FMI
CSB-BP498306FMI
CSB-MP498306FMI
CSB-EP498306FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi Probable tRNA sulfurtransferase (thiI) CSB-YP498307FMI
CSB-EP498307FMI
CSB-BP498307FMI
CSB-MP498307FMI
CSB-EP498307FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus equi subsp. equi 50S ribosomal protein L29 (rpmC) CSB-YP498308FMI
CSB-EP498308FMI
CSB-BP498308FMI
CSB-MP498308FMI
CSB-EP498308FMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>